Ich Q1a - Infectious Diseases

Relevant Publications

Identification and characterization of alkaline hydrolytic degradation products of ivacaftor by UPLC-PDA and UPLC-ESI-QTOF-MS techniques.

Issue Release: 2025

LC and LC-MS/MS Studies for the Separation and Identification of Impurities and Degradation Products of Betaxolol.

Issue Release: 2024

Analytical method development, identification, and characterization of stress degradation products of idelalisib by ultrahigh-performance liquid chromatography with photodiode array and ultrahigh-performance liquid chromatography with electrospray ionization quadrupole time-of-flight mass spectrometry studies.

Issue Release: 2024

Identification of degradation products of brivaracetam using liquid chromatography quadrupole time-of-flight tandem mass spectrometry: Degradation pathway elucidation.

Issue Release: 2024

Characterization of disulfide bridges containing cyclic peptide Linaclotide and its degradation products by using LC-HRMS/MS.

Issue Release: 2024

W/O/W microemulsions for nasal delivery of hydrophilic compounds: a preliminary study.

Issue Release: 2024

LC-HRMS and NMR studies for the characterization of degradation impurities of ubrogepant along with the in silico approaches for the prediction of degradation and toxicity.

Issue Release: 2024

Identification, characterization, and in silico ADMET prediction of nirmatrelvir and its degradation products using HPLC-PDA and LC-QTOF-MS/MS.

Issue Release: 2024

Tamarind seed polysaccharide-metformin insert: Higher ocular retention, slow-release, and efficacy against corneal burn.

Issue Release: 2024

Identification, characterisation and in silico ADMET prediction of ozenoxacin and its degradation products using high-performance liquid chromatography-photodiode array and liquid chromatography-quadrupole time-of-flight-tandem mass spectrometry.

Issue Release: 2024

Industry Perspective on Temperature Cycling Studies to Meet Regulatory Temperature Excursion Support Requirements: Survey Outcome and Recommendations.

Issue Release: 2023

Formulation and stability study of an oral paediatric phenobarbital 1% solution containing hydroxypropyl-β-cyclodextrins.

Issue Release: 2023

Forced degradation study of baricitinib and structural characterization of its degradation impurities by high-resolution mass spectrometry and nuclear magnetic resonance spectroscopy.

Issue Release: 2023

Systematic selection of Impurities, Development, and Validation of Related Substance Methods for Estradiol and Progesterone in a Combination Drug Product.

Issue Release: 2023

Characterization by LC-MS/MS of oxidized products identified in synthetic peptide somatostatin and cetrorelix submitted to forced oxidative stress by hydrogen peroxide: Two case studies.

Issue Release: 2023

Study on the hydrolytic degradation behaviour of bictegravir by LC-PDA-Q/TOF-MS/MS NMR and in silico toxicity assessment.

Issue Release: 2023

Separation and characterization of related substances of Lurasidone hydrochloride by LC-QTOF-MS techniques.

Issue Release: 2023

Development and validation of stability-indicating -HPLC method for the determination of related substances in novel nitroimidazole antituberculosis drug pretomanid: Robustness study by Design-Expert and application to stability studies.

Issue Release: 2022

Isolation, Characterization, and Toxicity Study of Stress Degradation Products of Pranlukast Hydrate.

Issue Release: 2022

LC and LC-MS/MS studies for identification and characterization of degradation products of d-tubocurarine chloride.

Issue Release: 2022

How are Flaviviridae infections diagnosed?

What is Hepatitis B?

What is Schistosomiasis?

Can Bacteria Cause Respiratory Symptoms?

How Does WHO Ensure Compliance with Health Regulations?

What are the Symptoms of Gonorrhea?

What is the Immune Response?

What are the Phases of the Inflammatory Response?

Why is Malaria a Significant Public Health Concern?

What are Imaging Studies?

Ich Q1a - Infectious Diseases

Relevant Publications

Partnered Content Networks

Relevant Topics